Examiner.com - Lifestyle Guru B. Smith Honored by Alzheimer’s Drug Discovery Foundation


Restaurateur, model, author and television host, B. Smith, was honored by the ADDF at The Pierre with The Charles Evans Award for promoting public awareness and helping to raise critical funds to combat Alzheimer's disease.

Associated Press - Lauder Jewels Auction to Benefit 2 Charities


Sotheby's says proceeds from the sale of 44 pieces of jewelry from the collections of Estee Lauder and Evelyn Lauder will benefit two charities. The sale of 33 jewels from Evelyn Lauder will support the Breast Cancer Research Foundation, which she founded. Eleven pieces from the collection of Estee Lauder will benefit the Alzheimer's Drug Discovery Foundation.

Philanthropy News Digest - Alzheimer’s Drug Discovery Foundation Invites Letters of Intent


Many treatments for Alzheimer’s disease have been shown to be safe and to have some positive effect in animal models. However, many of these potentially successful drugs have not been brought to human trial because of the increased cost and risk at that stage of research. The Alzheimer's Drug Discovery Foundation is responding to this problem with the Alzheimer’s Program to Accelerate Clinical Trials.

Toronto Star - Life with Alzheimer’s Patient Like Repeatedly Being Robbed


Alzheimer’s. Given that we were in the neurologist’s office at my request, I should not have been surprised — no, not surprised, but floored, shocked! — by the diagnosis. But I was. That visit to the doctor was the result of a cluster of seemingly small incidents.

Huffington Post - 5 Reasons to Be Optimistic About Alzheimer’s Research


Earlier this month I joined some of the world's preeminent physicians and neuroscientists in Copenhagen, Denmark, for the Alzheimer's Association's International Conference (AAIC). The six-day gathering is the largest of its kind and featured more than 100 sessions on a diverse range of Alzheimer's topics.

National Post - A First-Hand Account of Alzheimer’s ‘Long Goodbye’


Joan’s book, from the viewpoint of a caregiver, is an emotionally charged eulogy by a spouse who cared for her husband at home until the end. She is a member of the Board of Overseers of the Alzheimer’s Drug Discovery Foundation (ADDF), which was co-founded by Leonard A. and Ronald S. Lauder of the Estée Lauder cosmetics family. All book proceeds will support the ADDF’s Canadian arm.

Huffington Post - My Father’s Battle with Alzheimer’s


Like many people experiencing Alzheimer's in its early stages, my father began misplacing important objects and forgetting the names of people. As the disease progressed, his conversational skills became increasingly impaired, but through all of his changes, our emotional bond remained strong. I knew my father was following a typical Alzheimer's course. After more than 35 years of geriatric medical practice, I have watched this devastating disease unfold in similar ways for thousands of patients.

The Plain Dealer - Researchers From Ohio State, Emory Receive Grants


Researchers at Ohio State University and Emory University are the first to receive funding for their work in Alzheimer's through a collaboration between the Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation.

Bioscience Technology - Antidepressant Reduces Alzheimer’s Plaque Growth by 78 Percent


A common antidepressant can dramatically halt growth of Alzheimer’s plaque. A team from Missouri and Pennsylvania report today in Science Translational Medicine this reduction occurs in both humans and mice. It gives the drug, the selective serotonin reuptake inhibitor (SSRI) citalopram, a possible future role as a prophylactic—the first in Alzheimer’s disease (AD), if bigger studies are supportive.

Outsourced Pharma - Alzheimer’s Drug Discovery Foundation Raises $1.1 Million for New Clinical Trial


The Alzheimer’s Drug Discovery Foundation (ADDF) has announced it has raised more than $1.1 million for a clinical trial that will test the ability of existing drug rasagiline to treat Alzheimer’s. The clinical research will be led by Jeffrey Cummings, who is the director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada and Cleveland, Ohio.